Solvent-Mediated Polymorphic Transformations in Molten Polymers: The Account of Acetaminophen
- PMID: 35475360
- PMCID: PMC10950320
- DOI: 10.1021/acs.molpharmaceut.2c00035
Solvent-Mediated Polymorphic Transformations in Molten Polymers: The Account of Acetaminophen
Abstract
Solvent-mediated polymorphic transformations (SMPTs) employing nonconventional solvents (polymer melts) is an underexplored research topic that limits the application of polymer-based formulation processes. Acetaminophen (ACM), a widely studied active pharmaceutical ingredient (API), is known to present SMPTs spontaneously (<30 s) in conventional solvents such as ethanol. In situ Raman spectroscopy was employed to monitor the induction time for the SMPT of ACM II to I in polyethylene glycol (PEG) melts of different molecular weights (Mw, 4000, 10 000, 20 000, 35 000 g/mol). The results presented here demonstrate that the induction time for the SMPT of ACM II to I in PEG melts is driven by its diffusivity through the polymer melts. Compared to conventional solvents (i.e., ethanol) the mass transfer (diffusion coefficient, D) in melts is significantly hindered (Dethanol = 4.84 × 10-9 m2/s > DPEGs = 5.32 × 10-11-8.36 × 10-14 m2/s). Ultimately, the study proves that the induction time for the SMPT can be tuned by understanding the dispersant's physicochemical properties (i.e., η) and, thus, the D of the solute in the dispersant. This allows one to kinetically access and stabilize metastable forms or delay their transformations under given process conditions.
Keywords: active pharmaceutical ingredients; crystalline solid dispersion; diffusivity; melt; polymorphism; solvent-mediated polymorphic transformation.
Figures






References
-
- Hilfiker R Polymorphism: In the Pharmaceutical Industry; John Wiley and Sons, 2006.
-
- Brittain HG Polymorphism in Pharmaceutical Solids, 2nd ed.; Informa Healthcare, USA, Inc.: New York, 2009.
-
- Pan B; Wei H; Jiang J; Zong S; Lv P; Dang L Solution-Mediated Polymorphic Transformation of CL-20: An Approach to Prepare Purified Form δ Particles. J. Mol. Liq 2018, 265, 216–225.
-
- O’Mahony MA; Maher A; Croker DM; Rasmuson ÅC; Hodnett BK Examining Solution and Solid State Composition for the Solution-Mediated Polymorphic Transformation of Carbamazepine and Piracetam. Cryst. Growth Des 2012, 12 (4), 1925–1932.
-
- Guo N; Hou B; Wang N; Xiao Y; Huang J; Guo Y; Zong S; Hao H In Situ Monitoring and Modeling of the Solution-Mediated Polymorphic Transformation of Rifampicin: From Form II to Form I. J. Pharm. Sci 2018, 107 (1), 344–352. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources